Inovio Pharmaceuticals (INO) recently reported earnings for its second quarter of Fiscal Year 2022. Earnings per share came in at -$0.46 - a significant miss. Analysts had expected Inovio to report EPS of -$0.31. In the past nine quarters, it has missed estimates six times. The company is not profitable, and it has taken steps to reduce costs. Unfortunately, this is a temporary solution that extends its cash runway by only two years. Sales increased 187.5% year-over-year, with revenue hitting $784,395 compared to $272,824. The revenue increase was primarily driven by the delivery of its smart devices to the U.S. Department of Defense However, operating expenses grew by 25.
https://www.tipranks.com/news/inovio-stock-reports-q2-earnings-does-it-have-enough-cash?utm_source=advfn.com&utm_medium=referral
Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Inovio Pharmaceuticals Charts.
Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Inovio Pharmaceuticals Charts.